Peers of Acumen Pharmaceuticals Inc (ABOS)
Side-by-side comparison
Health Care · Biotechnology
Enterprise value divided by trailing twelve-month revenue. A capital-structure-neutral sales valuation metric.
Latest EV/Sales
150.15x
As of Dec 30, 2021
Beyond EV/Sales, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | EV/Sales |
|---|---|
| Dec 30, 2021 | 150.15x |
| Dec 29, 2021 | 119.47x |
| Dec 28, 2021 | 119.47x |
| Dec 27, 2021 | 141.56x |
| Dec 23, 2021 | 171.02x |
| Dec 22, 2021 | 167.33x |
| Dec 21, 2021 | 171.02x |
| Dec 20, 2021 | 157.52x |
EV/Sales = Enterprise Value / Revenue (TTM). Enterprise Value = Market Cap + Total Debt − (Cash & Short-Term Investments + Long-Term Investments).
EV/Sales is particularly useful in M&A analysis and for companies with significant debt.
Read the general EV/Sales definition, formula, and analyst usage guide.
EV/Sales guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
Side-by-side comparison